Learn More
Medchemexpress LLC Ripk3-in-1 | 2361139-70-8 | 99.3% | 50 MG

Supplier: Medchemexpress LLC HY13106450MG
RIPK3-IN-1 is a type II DFG-out inhibitor with primary activity against RIPK3. It also demonstrates inhibitory effects on RIPK1, RIPK2, and c-Met kinase. Additionally, it inhibits ABL, BRAF/V599E, MAP4K3, and SRC kinases.
- Inhibits RIPK3 with an IC50 of 9.1 nM
- Inhibits RIPK1 with an IC50 of 5.5 μM
- Inhibits RIPK2 with an IC50 of >10 μM
- Inhibits c-Met kinase with an IC50 of 1.1 μM
- Inhibits ABL with an IC50 of 0.37 μM
- Inhibits BRAF/V599E with an IC50 of 0.15 μM
- Inhibits MAP4K3 with an IC50 of 0.012 μM
- Inhibits SRC with an IC50 of 0.075 μM
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.